David Remillard
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Chromatin Remodeling and Cancer
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics
Papers in
-
- Protein Degradation and Inhibitors 9
- Ubiquitin and proteasome pathways 6
- Cancer-related gene regulation 2
- RNA Research and Splicing 2
- Chromatin Remodeling and Cancer 2
- Histone Deacetylase Inhibitors Research 1
-
- Multiple Myeloma Research and Treatments 6
- Co-authors
- James E. Bradner (4 shared papers)Scott A. Armstrong (3 shared papers)Gerard L. Brien (3 shared papers)Dennis L. Buckley (4 shared papers)Hyuk‐Soo Seo (4 shared papers)Sirano Dhe‐Paganon (4 shared papers)Nathanael S. Gray (3 shared papers)Matthew Sonnett (2 shared papers)
- Journals
- Angewandte Chemie International Edition (2 papers)Journal of the American Chemical Society (1 paper)Nature Cell Biology (1 paper)ACS Medicinal Chemistry Letters (1 paper)Nature Structural & Molecular Biology (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
David Remillard
11 papers receiving 784 citations
Peers
Comparison fields: 5 of 62
- Hematology 147
- Molecular Biology 725
- Pathology and Forensic Medicine 153
- Oncology 184
- Immunology 56
Countries citing papers authored by David Remillard
This map shows the geographic impact of David Remillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Remillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Remillard more than expected).
Fields of papers citing papers by David Remillard
This network shows the impact of papers produced by David Remillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Remillard. The network helps show where David Remillard may publish in the future.
Co-authors
The 25 scholars most cited alongside David Remillard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 248 | |
| 2 | 2017 | 204 | |
| 3 | 2018 | 148 | |
| 4 | 2022 | 72 | |
| 5 | 2023 | 40 | |
| 6 | 2022 | 26 | |
| 7 | 2023 | 15 | |
| 8 | 2017 | 15 | |
| 9 | 2019 | 12 | |
| 10 | 2016 | 12 | |
| 11 | 2021 | 5 |
About David Remillard
David Remillard is a scholar working on Molecular Biology, Hematology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 11 papers that have together received 797 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (6 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related gene regulation (2 papers), RNA Research and Splicing (2 papers), Chromatin Remodeling and Cancer (2 papers), Peptidase Inhibition and Analysis (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (147 citations), Molecular Biology (725 citations), Pathology and Forensic Medicine (153 citations), Oncology (184 citations) and Immunology (56 citations). David Remillard has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include James E. Bradner, Scott A. Armstrong, Gerard L. Brien, Dennis L. Buckley, Hyuk‐Soo Seo, Sirano Dhe‐Paganon, Nathanael S. Gray, Matthew Sonnett, Joshiawa Paulk and Shiva Dastjerdi. Their work appears in journals such as Angewandte Chemie International Edition, Journal of the American Chemical Society, Nature Cell Biology, ACS Medicinal Chemistry Letters and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.